These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 14618613

  • 1. Growth arrest by troglitazone is mediated by p27Kip1 accumulation, which results from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells.
    Motomura W, Takahashi N, Nagamine M, Sawamukai M, Tanno S, Kohgo Y, Okumura T.
    Int J Cancer; 2004 Jan 01; 108(1):41-6. PubMed ID: 14618613
    [Abstract] [Full Text] [Related]

  • 2. Troglitazone induces G1 arrest by p27(Kip1) induction that is mediated by inhibition of proteasome in human gastric cancer cells.
    Takeuchi S, Okumura T, Motomura W, Nagamine M, Takahashi N, Kohgo Y.
    Jpn J Cancer Res; 2002 Jul 01; 93(7):774-82. PubMed ID: 12149143
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells.
    Motomura W, Okumura T, Takahashi N, Obara T, Kohgo Y.
    Cancer Res; 2000 Oct 01; 60(19):5558-64. PubMed ID: 11034103
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. PPARgamma ligands inhibit cholangiocarcinoma cell growth through p53-dependent GADD45 and p21 pathway.
    Han C, Demetris AJ, Michalopoulos GK, Zhan Q, Shelhamer JH, Wu T.
    Hepatology; 2003 Jul 01; 38(1):167-77. PubMed ID: 12829999
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).
    Zhao Y, Tang Q, Ni R, Huang X, Wang Y, Lu C, Shen A, Wang Y, Li C, Yuan Q, Chen H, Cheng C, He S.
    Hum Pathol; 2013 Mar 01; 44(3):365-73. PubMed ID: 22995332
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. PPAR gamma ligand-induced apoptosis through a p53-dependent mechanism in human gastric cancer cells.
    Nagamine M, Okumura T, Tanno S, Sawamukai M, Motomura W, Takahashi N, Kohgo Y.
    Cancer Sci; 2003 Apr 01; 94(4):338-43. PubMed ID: 12824901
    [Abstract] [Full Text] [Related]

  • 12. A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells.
    Toyoda M, Takagi H, Horiguchi N, Kakizaki S, Sato K, Takayama H, Mori M.
    Gut; 2002 Apr 01; 50(4):563-7. PubMed ID: 11889080
    [Abstract] [Full Text] [Related]

  • 13. Skp2 promotes adipocyte differentiation via a p27Kip1-independent mechanism in primary mouse embryonic fibroblasts.
    Okada M, Sakai T, Nakamura T, Tamamori-Adachi M, Kitajima S, Matsuki Y, Watanabe E, Hiramatsu R, Sakaue H, Kasuga M.
    Biochem Biophys Res Commun; 2009 Feb 06; 379(2):249-54. PubMed ID: 19109928
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Degradation of p27(Kip1) at the G(0)-G(1) transition mediated by a Skp2-independent ubiquitination pathway.
    Hara T, Kamura T, Nakayama K, Oshikawa K, Hatakeyama S, Nakayama K.
    J Biol Chem; 2001 Dec 28; 276(52):48937-43. PubMed ID: 11682478
    [Abstract] [Full Text] [Related]

  • 17. Induction mechanism of apoptosis by troglitazone through peroxisome proliferator-activated receptor-gamma in gastric carcinoma cells.
    Yoshida K, Tanabe K, Fujii D, Oue N, Yasui W, Toge T.
    Anticancer Res; 2003 Dec 28; 23(1A):267-73. PubMed ID: 12680223
    [Abstract] [Full Text] [Related]

  • 18. Vitamin D arrests thyroid carcinoma cell growth and induces p27 dephosphorylation and accumulation through PTEN/akt-dependent and -independent pathways.
    Liu W, Asa SL, Fantus IG, Walfish PG, Ezzat S.
    Am J Pathol; 2002 Feb 28; 160(2):511-9. PubMed ID: 11839571
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of F-Box protein p45(SKP2) expression and stabilization of cyclin-dependent kinase inhibitor p27(KIP1) in vitamin D analog-treated cancer cells.
    Lin R, Wang TT, Miller WH, White JH.
    Endocrinology; 2003 Mar 28; 144(3):749-53. PubMed ID: 12586749
    [Abstract] [Full Text] [Related]

  • 20. A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma.
    Kim KR, Choi HN, Lee HJ, Baek HA, Park HS, Jang KY, Chung MJ, Moon WS.
    Oncol Rep; 2007 Oct 28; 18(4):825-32. PubMed ID: 17786342
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.